Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;22(9):1840-1844.
doi: 10.1016/j.jamda.2021.07.003. Epub 2021 Jul 19.

Prevalence and Predictors of Persistence of COVID-19 Symptoms in Older Adults: A Single-Center Study

Affiliations

Prevalence and Predictors of Persistence of COVID-19 Symptoms in Older Adults: A Single-Center Study

Matteo Tosato et al. J Am Med Dir Assoc. 2021 Sep.

Abstract

Objectives: Symptom persistence weeks after laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) clearance is a relatively common long-term complication of Coronavirus disease 2019 (COVID-19). Little is known about this phenomenon in older adults. The present study aimed at determining the prevalence of persistent symptoms among older COVID-19 survivors and identifying symptom patterns.

Design: Cross-sectional study.

Setting and participants: We analyzed data collected in people 65 years and older (n = 165) who were hospitalized for COVID-19 and then admitted to the Day Hospital Post-COVID 19 of the Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS (Rome, Italy) between April and December 2020. All patients tested negative for SARS-CoV-2 and met the World Health Organization criteria for quarantine discontinuation.

Measures: Patients were offered multidisciplinary individualized assessments. The persistence of symptoms was evaluated on admission using a standardized questionnaire.

Results: The mean age was 73.1 ± 6.2 years (median 72, interquartile range 27), and 63 (38.4%) were women. The average time elapsed from hospital discharge was 76.8 ± 20.3 days (range 25-109 days). On admission, 137 (83%) patients reported at least 1 persistent symptom. Of these, more than one-third reported 1 or 2 symptoms and 46.3% had 3 or more symptoms. The rate of symptom persistence was not significantly different when patients were stratified according to median age. Compared with those with no persistent symptoms, patients with symptom persistence reported a greater number of symptoms during acute COVID-19 (5.3 ± 3.0 vs 3.3 ± 2.0; P < .001). The most common persistent symptoms were fatigue (53.1%), dyspnea (51.5%), joint pain (22.2%), and cough (16.7%). The likelihood of symptom persistence was higher in those who had experienced fatigue during acute COVID-19.

Conclusions and implications: Persistent symptoms are frequently experienced by older adults who have been hospitalized for COVID-19. Follow-up programs should be implemented to monitor and care for long-term COVID-19-related health issues.

Keywords: COVID-19; SARS-CoV-2; aging; fatigue; geriatrics; long COVID.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Proportion of patients with persistent symptoms on admission in the whole sample and according to sex and median age (72 years).
Fig. 2
Fig. 2
COVID-19–related symptoms. The figure shows the proportion of patients with specific COVID-19–related symptoms during the acute phase of the disease and on admission.

References

    1. Prem K., Liu Y., Russell T.W. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: A modelling study. Lancet Public Health. 2020;5:e261–e270. - PMC - PubMed
    1. Sanyaolu A., Okorie C., Marinkovic A. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2020 Jun 25. [Epub ahead of print] - PMC - PubMed
    1. Wiersinga W.J., Rhodes A., Cheng A.C. Pathophysiology, transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19): A review. JAMA. 2020;324:782–793. - PubMed
    1. Landi F., Carfì A., Benvenuto F., Gemelli Against COVID-19 Post-Acute Care Team Predictive factors for a new positive nasopharyngeal swab among patients recovered from COVID-19. Am J Prev Med. 2021;60:13–19. - PMC - PubMed
    1. Carfì A., Bernabei R., Landi F., Gemelli Against COVID-19 Post-Acute Care Study Group Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603–605. - PMC - PubMed